DTC

Deep Track Capital Portfolio holdings

AUM $3.11B
1-Year Est. Return 13.6%
This Quarter Est. Return
1 Year Est. Return
+13.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.11B
AUM Growth
+$22.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1 +$150M
2 +$83.7M
3 +$45.5M
4
APLS icon
Apellis Pharmaceuticals
APLS
+$34.6M
5
JBIO
Jade Biosciences
JBIO
+$25.1M

Top Sells

1 +$264M
2 +$82M
3 +$62.1M
4
AMGN icon
Amgen
AMGN
+$35.2M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$30.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
1
Guardant Health
GH
$8.41B
$221M 7.09%
4,250,000
-1,193,721
IONS icon
2
Ionis Pharmaceuticals
IONS
$11.6B
$193M 6.2%
4,891,544
+327,337
PTGX icon
3
Protagonist Therapeutics
PTGX
$4.71B
$179M 5.75%
3,245,899
+245,899
DVAX icon
4
Dynavax Technologies
DVAX
$1.15B
$176M 5.66%
17,791,486
INSM icon
5
Insmed
INSM
$34.5B
$176M 5.65%
1,750,000
+1,495,249
AKRO icon
6
Akero Therapeutics
AKRO
$4.3B
$162M 5.21%
3,042,598
-167,672
IMVT icon
7
Immunovant
IMVT
$3.03B
$152M 4.87%
9,500,000
OCUL icon
8
Ocular Therapeutix
OCUL
$2.59B
$133M 4.25%
14,294,420
APLS icon
9
Apellis Pharmaceuticals
APLS
$3.05B
$121M 3.89%
7,000,000
+2,000,000
CYTK icon
10
Cytokinetics
CYTK
$7.05B
$121M 3.87%
3,650,000
+576,147
GPCR icon
11
Structure Therapeutics
GPCR
$1.59B
$106M 3.41%
5,133,917
+1,033,917
ETNB icon
12
89bio
ETNB
$2.19B
$93.3M 2.99%
9,500,000
+183,667
AXSM icon
13
Axsome Therapeutics
AXSM
$6.24B
$83.7M 2.68%
+801,371
VRDN icon
14
Viridian Therapeutics
VRDN
$1.88B
$75.2M 2.41%
5,380,449
TARS icon
15
Tarsus Pharmaceuticals
TARS
$3.16B
$70.9M 2.27%
1,750,000
+265,734
PCVX icon
16
Vaxcyte
PCVX
$5.66B
$69.9M 2.24%
2,150,000
+1,400,000
NRIX icon
17
Nurix Therapeutics
NRIX
$771M
$69.1M 2.22%
6,064,910
+564,910
GERN icon
18
Geron
GERN
$785M
$60.6M 1.94%
43,000,000
+4,823,749
IMCR icon
19
Immunocore
IMCR
$1.69B
$56.5M 1.81%
1,800,000
+388,598
RARE icon
20
Ultragenyx Pharmaceutical
RARE
$3.27B
$49.1M 1.57%
1,350,000
MAZE
21
Maze Therapeutics
MAZE
$1.25B
$48.5M 1.55%
3,948,910
+679,784
ANIP icon
22
ANI Pharmaceuticals
ANIP
$2.05B
$45.7M 1.46%
700,000
XENE icon
23
Xenon Pharmaceuticals
XENE
$3.25B
$42.3M 1.36%
1,350,000
+350,000
DNTH icon
24
Dianthus Therapeutics
DNTH
$1.43B
$41.6M 1.33%
2,233,148
-124,554
CLDX icon
25
Celldex Therapeutics
CLDX
$1.76B
$40.7M 1.31%
2,000,000